Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piet Ost

Showing results (101-110 of 334) with videos related to

Pageof 34
Sort By:
Practical Radiation Oncology|October 18, 2017
Prostate cancer-specific PET radiotracers: A review on the clinical utility in recurrent diseaseJaden D Evans, Krishan R Jethwa, Piet Ost, et al.
International Journal of Radiation Oncology, Biology, Physics|October 22, 2011
Improving positioning in high-dose radiotherapy for prostate cancer: safety and visibility of frequently used gold fiducial markersValérie Fonteyne, Piet Ost, Geert Villeirs, et al.
European Urology|June 6, 2026
A Multidisciplinary Approach to Prevention and Treatment of Late Genitourinary Adverse Events After Radiotherapy for Prostate CancerAmar U Kishan, Giulio Francolini, Declan G Murphy, et al.
European Urology|November 20, 2022
Incorporating Prostate-specific Membrane Antigen Positron Emission Tomography in Management Decisions for Men with Newly Diagnosed or Biochemically Recurrent Prostate CancerLaura Bukavina, Amy N Luckenbaugh, Michael S Hofman, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001)Piet Ost, Valérie Fonteyne, Wilfried De Neve, et al.
Technology in Cancer Research & Treatment|April 5, 2023
Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER StudyValérie Fonteyne, Willeke Danckaert, Piet Ost, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2012
Acute radiation-induced nocturia in prostate cancer patients is associated with pretreatment symptoms, radical prostatectomy, and genetic markers in the TGFβ1 geneSofie De Langhe, Kim De Ruyck, Piet Ost, et al.
Technology in Cancer Research & Treatment|August 2, 2018
Stereotactic Body Radiotherapy for Primary Prostate CancerGargi Kothari, Andrew Loblaw, Alison C Tree, et al.
Frontiers in Immunology|September 24, 2021
Clinical Relevance of Serum Kyn/Trp Ratio and Basal and IFNγ-Upregulated IDO1 Expression in Peripheral Monocytes in Early Stage MelanomaAnnabel Meireson, Liesbeth Ferdinande, Marc Haspeslagh, et al.
European Urology|May 8, 2017
Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic ReviewValérie Fonteyne, Piet Ost, Joaquim Bellmunt, et al.
Pageof 34

Showing results (101-110 of 334) with videos related to

Sort By:
Pageof 34
Practical Radiation Oncology|October 18, 2017
Prostate cancer-specific PET radiotracers: A review on the clinical utility in recurrent diseaseJaden D Evans, Krishan R Jethwa, Piet Ost, et al.
International Journal of Radiation Oncology, Biology, Physics|October 22, 2011
Improving positioning in high-dose radiotherapy for prostate cancer: safety and visibility of frequently used gold fiducial markersValérie Fonteyne, Piet Ost, Geert Villeirs, et al.
European Urology|June 6, 2026
A Multidisciplinary Approach to Prevention and Treatment of Late Genitourinary Adverse Events After Radiotherapy for Prostate CancerAmar U Kishan, Giulio Francolini, Declan G Murphy, et al.
European Urology|November 20, 2022
Incorporating Prostate-specific Membrane Antigen Positron Emission Tomography in Management Decisions for Men with Newly Diagnosed or Biochemically Recurrent Prostate CancerLaura Bukavina, Amy N Luckenbaugh, Michael S Hofman, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001)Piet Ost, Valérie Fonteyne, Wilfried De Neve, et al.
Technology in Cancer Research & Treatment|April 5, 2023
Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER StudyValérie Fonteyne, Willeke Danckaert, Piet Ost, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2012
Acute radiation-induced nocturia in prostate cancer patients is associated with pretreatment symptoms, radical prostatectomy, and genetic markers in the TGFβ1 geneSofie De Langhe, Kim De Ruyck, Piet Ost, et al.
Technology in Cancer Research & Treatment|August 2, 2018
Stereotactic Body Radiotherapy for Primary Prostate CancerGargi Kothari, Andrew Loblaw, Alison C Tree, et al.
Frontiers in Immunology|September 24, 2021
Clinical Relevance of Serum Kyn/Trp Ratio and Basal and IFNγ-Upregulated IDO1 Expression in Peripheral Monocytes in Early Stage MelanomaAnnabel Meireson, Liesbeth Ferdinande, Marc Haspeslagh, et al.
European Urology|May 8, 2017
Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic ReviewValérie Fonteyne, Piet Ost, Joaquim Bellmunt, et al.
Pageof 34